Stocks
Soligenix, Inc.SNGX
NASDAQHealthcareBiotechnology$0.36
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing treatments for rare diseases and biodefense threats, including a vaccine candidate for Ebola and therapies for cutaneous T-cell lymphoma. Its lead programs target unmet medical needs in oncology and infectious diseases, with revenue potential tied to government contracts and regulatory milestones.
52W Range: $0.28-$1.70
Congressional Interest in Soligenix, Inc. (SNGX)
No congressional trades have been disclosed for Soligenix, Inc. (SNGX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading SNGX?
No congressional trades found for this stock.